RTTNews | Dec 10, 2021 01:30PM EST

13:30 Friday, December 10, 2021 (RTTNews.com) - New Jersey-based healthcare company, Rafael Holdings, Inc. (RFL) dropped 13% on Friday despite the company not posting any stock-related news that can affect the stock. The company operates in two segments. One is its early stage pharma companies and the other is its commercial real estate business primarily based in the United States and Israel. The company also has a metastatic pancreatic drug named Devimistat which is in its Phase II trial. The stock is currently trading at $5.20, down $0.75 or 12.69% since the previous close at $5.95. The stock opened at $5.73 in the morning. In the 52-week period, the shares have ranged between $5.06 and $66.44 per share.

Read the original article on RTTNews ( https://www.rttnews.com/3248568/rafael-shares-drop-12.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved